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Current articular cartilage tissue engineering endeavors, using synthetic polymers
as scaffolds, have been somewhat successful. However, the use of these materials has
not yielded a satisfactory, functional replacement for articular cartilage. Therefore, this
project focuses on an alternative to these materials, chitosan, which is a naturally
occurring biopolymer.
The first project objective was to fabricate and analyze bulk, porous chitosan
scaffolds, based on total porosity, average pore diameter, mechanical integrity, and
degradation susceptibility. Secondly, scaffolds were evaluated in terms of their ability to
support neochondrogenesis, including assessments of cell attachment and viability, cell
morphology, and the biosynthesis of proteoglycan and type-II collagen-rich extracellular
matrix.
Results indicated that chitosan scaffolds possessing an interconnecting, porous
structure could be easily created through a simple freezing and lyophilization process,

and these scaffolds did support neochondrogenesis. Results suggest chitosan may be a
useful alternative to synthetic polymers for use in cartilage tissue engineering
applications.
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CHAPTER I
INTRODUCTION AND REVIEW OF LITERATURE
Tissue and organ failure accounts for nearly one half of the total annual healthcare
expenditure in the United States, or approximately $400 billion (Lewis, 1995). Injury
and disease can affect something as simple as skin or can affect the more complex organs
like the kidneys, liver, or heart. Treatment options for these diseases and injuries include
transplants, surgical repair, prosthetic devices, mechanical support, and in some cases,
drug therapy; however, these treatments often provide unsatisfactory repair or
maintenance. In the case of transplantation, there are donor shortages and problems with
immunosuppression. Though the probability of rejection declines with each passing
month following a transplant, the possibility persists throughout the patient’s life. In the
case of surgery, repairs are often imperfect and require follow-up procedures. Prosthetic
and mechanical support devices do not replace the full and proper function of the
damaged tissue or organ, which often leads to continued disease progression. Drug
therapy is only available for some diseases, and can be associated with unwanted side
effects such as heart rate and blood pressure fluctuations or nausea and loss of appetite
for example. Because these options do not provide satisfactory restoration of organ
and/or tissue function, other avenues to restore, repair, and/or maintain tissues and organs
must be pursued. One of these avenues is the emerging science of tissue engineering.
1
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Tissue Engineering
"Tissue engineering is the application of principles and methods of engineering
and life sciences toward fundamental understanding of structure-function relationships in
normal and pathological mammalian tissues and the development of biological substitutes
to restore, maintain, or improve tissue functions" (NSF Workshop on Tissue Engineering,
1988). In other words, tissue engineering involves the use of cells and extracellular
components, either synthetic or natural, to create replacement, implantable parts to
restore, maintain, or repair the function of damaged/diseased tissues and organs (Nerem,
1991). This approach may be applied toward several goals. Among these goals are
providing replacement parts or cellular prostheses for the human body, providing vehicles
to deliver engineered cells to an organism, creating tissue models with cells to study the
states of diseases using aberrant cells, surfacing non-biological apparatuses, and
providing acellular parts capable of regenerating tissues.
The first important phase of any tissue engineering endeavor is to evaluate the
types, ratios, and organization of the cells necessary to produce the tissue or organ of
interest. In general, one chooses a substrate material upon which to culture the cells that
will enhance their organization in three dimensions and possibly provide initial
mechanical integrity to the cell-polymer construct.

This material should be

biocompatible, sterilizable, and have a large surface area on which new tissue can grow
(Paige and Vacanti, 1995). Applications may also require the scaffold material to be
biodegradable. Secondly, the cells of the tissue or organ of interest are seeded onto the
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substrate and cultured for a period of time in vitro. Finally, the cell-substrate construct
may be implanted at the site of tissue damage. in vivo.
This general approach is currently being used in many tissue engineering research
labs around the world and has proven clinically successful, as evidenced by commercially
available tissue engineered skins. Other engineered tissues and organs such as cartilage,
heart valves, blood vessels, bone, intestine, and tendon, among many others, also have
promise for clinical success. Obviously the more complex the tissue or organ, the more
complex the engineering process, but the same general methods are still employed. One
tissue that is very well suited for tissue engineering methods is articular cartilage because
of its fairly simple composition, one cell type, and lack of vascularity.

Articular Cartilage
Articular cartilage of the knee is a highly specialized connective tissue
responsible for cushioning and lubricating.

It is avasular, aneural, alymphatic, is

composed mostly of water, and contains only one cell type, the chondrocyte. Articular
cartilage has four distinct zones or areas. The first is called the superficial zone, which is
the thinnest zone and forms the gliding surface of the joint. The second zone, the
transition zone, lies just beneath the superficial zone and is a much more voluminous
zone than the superficial zone. The third zone is called the deep or radial zone. This
zone occupies the largest part of articular cartilage. The last zone, the zone of calcified
cartilage, lies just above the subchondral bone and acts to separate the softer cartilage of
the radial zone from the hard bone beneath. The zones are oriented in such a way to
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compensate for different forces at the surface in relation to forces deeper in the tissue.
Thus, the variation in the morphology of the zones reflects their structural role in
withstanding the different forces within the joint.
The dry weight cartilage as a whole is composed of chondrocytes and the
extracellular matrix (ECM) they synthesize. This extracellular matrix contains cartilagespecific proteoglycans, type II collagen, and other noncollagenous proteins, whose
purpose is to provide the overall cushioning and lubricating properties of articular
cartilage (Buckwalter, 1983).
The proteoglycans found in the ECM consist of a protein core composed of three
regions and are responsible for the resiliency and stiffness to compression of articular
cartilage. The three regions of the core protein include a hyaluronic acid binding region,
a keratin sulfate-rich region, and a chondroitin sulfate-rich region. Hyaluronic acid,
keratin sulfate, and chondroitin sulfate are glycosaminogylcans, which are repeating
disaccharide units usually containing glucosamine or galactosamine and hexuronic acid
or galactose.

Proteoglycans either exist as monomers, one unit (Figure 1A), or

aggregates, which are groups of monomers connected via link proteins to a hyaluronic
acid filament (Figure 1B).
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Figure 1A. Proteoglycan Monomer. B. Proteoglycan Aggregate
Type II collagen provides the form and tensile strength of cartilage. Collagen, in
general, is composed of three alpha chains consisting of about 1000 amino acids each.
The three alpha chains are tight left-handed helices that are bound together in a righthanded helix to form what is called tropocollagen.

The spontaneous, but specific

association of these tropocollagen molecules in the extracellular matrix of cartilage forms
collagen microfibrils. Type II collagen can be distinguished from other types of collagen
by its high hydroxylysine content, the high content of carbohydrates bound to the
hydroxylysine, and its small diameter fibrils (Buckwalter, 1983).
Articular cartilage is particularly vulnerable to injury by trauma, disease, or
congenital abnormalities.

Because cartilage is avascular, alypmhatic, and aneural

(Buckwalter, 1983, Huber et al, 2000), disease and injury often go undetected until severe
damage has already occurred (Buckwalter, 1983). Once the tissue is damaged, it has
little capacity for intrinsic repair.

Repair that does occur often results in

fibrocartilaginous areas at the injury site consisting of clumps of cells bound together by
sheets of collagen that do not exhibit the structural organization or strength for healthy
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articular cartilage function (Huber, 2000, Buckwalter, 1983). For this reason, disease
often progresses to severe degenerative osteoarthritis. Osteoarthritis affects an estimated
20.7 million Americans and accounts for over $67 million in lost wages and productivity
annually.
Articular Cartilage Tissue Engineering
Articular cartilage is a good candidate tissue for tissue engineering. Its lack of
vasculature and its single cell type allow the engineer to create a construct consisting
simply of polymer and chondrocytes. Chondrocytes are easily obtained from native
cartilage, preferably from a young source, through a simple enzymatic digestion
procedure. These cells are considered primary cells and already possess the chondrocyte
phenotype.

Chondrocytes also proliferate rapidly in monolayer, which allows the

polymer substrate to be covered in a relatively short time period. Another attractive
quality of articular cartilage is that chondrocyte metabolism in vivo is anaerobic, using
the glycolitic pathway, which is the usual mechanism of cell metabolism in vitro (Muir,
1995; Lane et al, 1977); therefore, culture conditions do not create metabolic stresses on
the chondrocytes.
Mesenchymal stem cells (MSC’s) may also be used to engineer articular cartialge.
Mesenchymal stem cells have the potential to become one of many different types of
cells, including muscle, fat, bone, cartilage, tendon, and marrow stroma. The exact
environment needed for MSC’s to differentiate into each different cell type is not well
understood, but includes varying combinations of nutrients, growth factors, spatial
organization, and mechanical stimulus (Pittenger et al, 1999).
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Once the type of cell to be used has been chosen, the next most important decision
becomes the choice of the polymer substrate material. The most extensively investigated
materials for this application are the synthetic polymers poly(glycolic acid) (PGA),
poly(L-lactic acid) (PLLA), and copolymers of the two, poly(DL-lactic-co-glycolic acid)
(PLGA) (Freed et al., 1993; Sittinger et al., 1996; Baker and Goodwin, 1997; Grande et
al., 1997). Using these polymers, neocartilage has been engineered that resembles native
cartilage in morphology and composition; however, there have been no reports of tissue
engineered cartilage that meet the functional requirement to replace native cartilage
(Dounchis et al., 2000; Chu et al., 1995). Therefore, alternative polymers are currently
being investigated, including the natural polymers collagen and hyaluronic acid
(Hutmacher, 2000, Vaissiere et al 1999, Chevallay and Herbage, 1999). These are very
attractive materials because they are major constituents of the extracellular matrix of
native articular cartilage and have been implicated in important cell signaling events that
occur during chondrogenesis (Allemann et al., 2001). Another attractive material is
chitosan, a derivative of a naturally occurring biopolymer, whose chemical structure
resembles that of hyaluronic acid. Chitosan has been suggested as a bipolymer for use in
many medical and non-medical applications (Suh and Matthew, 2000) and is the topic of
this research.

Chitosan
Chitosan is a modified carbohydrate polymer derived from chitin, a structural,
linear polysaccharide found in the exoskeletons of crustaceans. Chitin is the second most
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abundant biopolymer found in nature, second only to cellulose, and is an abundant waste
product of the seafood industry. It accounts for approximately one third of the dry weight
of the waste shells. Chitin can be easily processed into chitosan, typically by an initial
decalcification in dilute, aqueous hydrochloric acid solution, and then deproteination in
dilute aqueous sodium hydroxide. The product is subsequently decolorized in 0.5%
potassium permanganate (aqueous) and oxalic acid (aqueous) or sunshine, and finally
deacetylated in hot, concentrated (40-50%) sodium hydroxide solution to produce the
final product, chitosan. Chitosans are a family of poly-D-glucosamine units that vary in
their degree of deacetylation and molecular weight.
There are two broad categories to explain chitosan. It is either a random-type
copolymer of GlcNAc and D-glucosamine termed heterogeneous chitosan, or it is
sequenced blocks of acetylated glucosamines termed homogeneous chitosan (Aiba,
1993). These chitosans not only have different physical forms, but they can also act quite
differently under certain environmental conditions.
Both types of chitosans have been shown to possess characteristics that make
them suitable as a tissue engineering cell substrate. Certain chitosans are antimicrobial,
biocompatible, and degrade to absorbable oligosaccharides (Denuziere, 1998). Chitosan
can be easily processed into porous scaffolds, films, and beads (Jarry et al, 2001).
Especially important for cartilage tissue engineering, is that chitosan is polycationic, and
its structure is similar to hyaluronic acid, an important molecule in the extracellular
matrix of articular cartilage (Suh et al, 2000). Two-dimensional substrates of chitosan
have been shown to support the synthesis of cartilaginous extracellular matrix
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components in monolayer culture (Lahiji et al, 2000), and have been shown to enhance
osteogenesis in vitro (Klokkevold et al, 1996).

Antimicrobial Action of Chitosan
Some chitosans have been shown to have antimicrobial and bacteriostatic
potential. These chitosans inhibit microbial activity by attacking the microbial cell wall.
Chitosan has been observed to act more quickly on fungi and algae than on bacteria
(Cuero, 1999); however, like other properties of chitosan, this activity may be dependent
on the type of chitosan, chitosan molecular weight, and degree of deacetylation, among
other factors influencing the environment in which the chitosan is placed.

This

antimicrobial activity of chitosan has been investigated for use as an anti-spoilage
mechanism in food research. Davydova et al (1999) found mildy hydrolyzed chitosan to
exhibited antimicrobial activity against spoilage organisms.

Chitosan has also been

investigated in medical applications as a possible mechanism to prevent secondary
infections or to avert immunological rejections of implants and/or transplants. Felt et al
(2000) studied the antibacterial effects of chitosan against E. coli and S. aureus, in a study
on the efficacy of using chitosan as a tear substitute in cases of dry eye to prevent
secondary infections. They found that the minimal inhibitory concentration of chitosan
against E. coli was as low as 0.375 mg/ml and as low as 0.15 mg/ml against S. aureus
(Felt et al, 2000). In another study by Rhoades et al (2000) the interactions of bacterial
endotoxins, lipopolysaccharide (LPS) and lipopolysaccharide-protein complex (LPPC),
with chitosan were investigated. These endotoxins are a major component of the outer
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membranes of gram-negative bacteria. The interaction between these endotoxins and
chitosan was determined to be quite complicated and depended not only on the molecular
organization of the endotoxin, but also on the degree of polymerization of the chitosan,
with the highest affinity being between longer O-chain endotoxins and lower molecular
weight chitosans. They concluded this binding between chitosans and LPS decreased
acute toxicity (Rhoades et al, 2000).

Biodegradation of Chitosan
An important consideration in cartilage tissue engineering applications is the rate
at which the polymer matrix used to organize the cells in vitro biodegrades, if at all. The
presence of non-biodegradable foreign materials in soft tissue often causes acute foreignbody reactions elicited by the body’s immune system that can result in severe
inflammation and soreness around the implant site. However, while biocompatible,
biodegradable polymers may elicit an initial immune response, it is often possible to
control their degradation rate to decrease the length of time during which foreign material
is in contact with living tissue.
Many studies have shown that chitin and chitosan are biodegradable polymers,
and that they degrade in vivo mainly through their susceptibility to enzymatic hydrolysis
mediated by lysozyme, which is ubiquitous in the human body; however, this action has
been determined to be dependent on factors including pH, type of chitin or chitosan, and
chitosan preparation method.

Davies et al (1969) determined that chitosan is most

susceptible to hydrolysis by lysozyme at pH 5.2, and the optimum range of pH values has
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been determined to be between pH 5.2 and 8.0 (Davies et al, 1969 and Shigemasa et al
1993).
Pangburn et al. (1982) studied the effect of deacetylation on the susceptibilities of
chitin and chitosan to lysozyme and concluded that pure chitin (0% deacetylation) is most
susceptible to lysozyme, while pure chitosan (100% deacetylation) cannot be degraded by
lysozyme. In 1990, Sashiwa et al. (1990) studied the relative rates of degradation of six
chitosans varying in degree of deacetylation (45%, 66%, 70%, 84%, 91%, and 95%), but
and found that 70% deacetylated chitosan degraded most quickly.
Shigemasa et al. (1993) investigated the effects preparation methods had on
degradation. They found that for the same molecular weight and degree of deacetylation,
homogeneously prepared chitosans were more susceptible to hydrolysis by lysozyme than
heterogeneously prepared chitosans (Shigemasa et al, 1993). These data were consistent
with results from Lee et al. (1995). Their findings suggest that there must be segments
consisting of at least three consecutive N-acetyl sugar residues for lysozyme to be
effective. Block segments of N-acetyl sugars are commonly found in homogeneous
chitosans. Segments consisting of only glucosamine were not susceptible to hydrolysis
by lysozyme (Lee, 1995).
In a more recent study Varum et al. (1996) noted that the specificity for most
enzymatically catalyzed reactions usually included the number of sugar residues
recognized by the active site of the enzyme, and found that this was in fact true for the
lysozyme-chitosan enzyme-substrate complex as well. The lysozyme active cleft consists
of six subsites, AL – FL. They found a high affinity of the DL and EL subsites of the

12
active cleft of the lysozyme for A-units of chitosan (oligosaccharides with acetylated
reducing ends) rather than D-units (oligosaccharides with deacetylated reducing ends).
The FL subsite showed no selectivity for A- or D-units. Their results also suggested that
the nearest neighbor to the A-unit in the DL subsite should also be an A-unit for
hydrolysis to occur at an appreciable rate (Varum et al., 1996). Figure 2 depicts the
lysozyme-chitosan complex and shows the specificity of these lysozyme subsites for
certain chitosan subunits.

Lysoyme Binding aCleft
Subsites (AL – FL)

A
a
B
C
D

a

a
Proposed
Cleavage Site

E
F

a or d

Figure 2. Schematic Illustration of Lysozyme Binding Cleft Subsites and Their
Specificity for a- and /or d-units of the Chitosan Chain. The Arrow
Illustrates the Proposed Cleavage Site of the Chitosan Chain.
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While there is still conflicting data as to the exact products of chitosan
degradation in vivo, the products have been identified as simple oligosaccharides that are
not harmful and are often further degraded by b-glucosaminidases before being easily
flushed from the body (Onishi and Machida, 1999). These oligosaccharides are usually
tetramers, pentamers, and hexamers, which suggests that lysozyme acts as an endozyme.
If chitosan were acting as an exozyme, oligomers resulting from enzymatic degradation
would include the monomers and dimers of D-glucose.

Chitosan Biocompatibility and Charge
Tomihata and Ikada (1997) studied how degradation rate related to
biocompatibility of chitosan films. Results showed a marked decrease in the degradation
of deacetylated films when the degree of deacetylation increased from 69% to 73%. The
more rapidly degrading 69% deacetylated chitosan showed strong cell adhesion
properties, but elicited an acute inflammation reaction when implanted subcutaneously in
rats. This was most likely due to the accumulation of degradation products at the implant
site, caused by rapid degradation of this film. On the other hand, implanted films of 73%
deacetylation or more did not elicit a strong foreign-body reaction, but still displayed
very strong cell adhesion properties. While cell adhesion properties of chitosan are
attributed in part to its cationicity, other implantable materials with a positive charge
often elicit acute foreign-body reactions in vivo. Tomihata and Ikada believe the lack of
severe reaction to more highly deacetylated chitosan was related to the zeta potential of
these films. Zeta potential is a measure of the potential at the boundary between a
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particle and a continuous layer, or slipping plane. More highly deacetylated chitosans,
while still possessing a strong cationic charge due to their primary amines, display lower
zeta potentials than their less highly deacetylated counterparts. The lower zeta potential
of more highly deacetylated chitosans in concert with their slower degradation are
believed responsible for the lack of an acute inflammation reaction at the implant site
(Tomihata and Ikada, 1997).

Cellular and Tissue Responses to Chitosan
Chitosan’s cationic nature appears to be the main mechanism by which cells are
attracted to this polymer; however, the degree of cell attachment has also been shown to
be related to the percent deacetylation of the chitosan. Prasitsilp et al (2000) studied how
degree of deacetylation affected in vitro cellular responses to chitosan from two different
sources, shrimp and cuttle fish. They tested four chitosan substrates, two from each
source, differing by about 10% in deacetylation and ranging between 76% and 90%
deacetylation.

Results indicated that cells more readily attached to more highly

deacetylated chitosans from both sources. Their results also indicate that adherence and
growth of cells cultured in extract mediums from the more highly deacetylated chitosans
was greater than that of cells cultured in extract mediums from lesser deacetylated
chitosans.

When cultured in the presence of discs made from the four different

substrates, cells readily attached to and grew on discs of higher deacetylation while
forming a ring around discs of lesser deacetylation; however, cells in the presence of
discs of lesser deacetylation eventually began to migrate onto the discs when cultures
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were allowed to become overgrown (Prasitslip et al, 2000). This suggested the lack of an
inhibition zone around the chitosan, which indicated that the chitosan was not cytotoxic.
The in vivo chitosan-tissue biocompatibility studies tend to be in agreement with
the in vitro cell response studies. In vivo studies of tissue response to films of chitosan by
Tomihata et al (1997) showed a marked increase in chitosan-tissue biocompatibility as
chitosan deacetylation increased (Tomihada and Ikada, 1997). Hidaka et al. (1999)
studied the histopathological and immunohistochemical effects of chitosan membranes
differing in degree of deacetylation implanted over rat calvaria. Their findings suggested
that chitosan membranes with percentages of deacetylation ranging between 65% and
80% enhanced osteogenesis at the site of implantation, while those membranes of 94% or
100% deacetylation showed only minimal osteogenesis; however, membranes of lesser
deacetylation elicited a more marked inflammation response than membranes of higher
deacetylation. Hidaka et al suggested the need to control the inflammation response
before chitosan could be considered in clinical applications (Hidaka et al, 1999).
Muzzarelli et al (1988) studied the biological activity of chitosan from an
ultrastructural standpoint by investigating tissue repair induced by chitosan. They used
86.8% deacetylated chitosan in direct contact with or in substitution of dura mater, a
tough, fibrous tissue found in the brain and spinal cord. Results indicated that chitosan
seemed to mimic the function of the dura mater and had a significant inductive and
stimulatory effect on the rebuilding of this connective tissue. Muzzarelli et al suggested
that chitosan may be considered as a structural biomaterial for the repair of connective
tissues because of its structural similarity to glycosaminoglycans found in the matrix of
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these tissues (Muzzarelli et al, 1988). Others have proposed using chitosan in substrates
used to treat burns and other severe skin lesions. These research teams have found that
areas treated with substrates incorporating chitosan demonstrated an early return to
normal skin color, facilitated rapid wound epithelializaiton and regeneration of nerves
within the vascular dermis (Stone et al, 2000), and promoted skin with morphological
equivalence to normal skin (Shahabeddin et al, 1990). After their first clinical uses of a
dermal substrate incorporating chitosan, Damour et al believed chitosan was a promising
candidate as an alternative to a skin homograft because of its availability and its
exemption from micro-organism transmission (Damour et al, 1994).
Chitosan has also been shown to have great potential to enhance osteogenesis
when used as a film or two-dimensional culture substrate. In a study to evaluate the
effect of chitosan on osteoblast differentiation and bone formation in vitro, Klokkevold et
al (1996) cultured mesenchymal stem cells from fetal Swiss Webster mice calvariae in
the presence of 200 ml of a 2mg/ml chitosan/acetic acid solution or in control wells that
were either untreated or treated only with 0.2% acetic acid.

Results indicated a

significantly higher number of osteoblast colonies in chitosan-treated wells as compared
to control wells, while bone formation was also higher, but not statistically significant in
the chitosan treated wells.

These results suggested that chitosan did potentiate the

differentiation of osteoprogenitor cells and may have also enhanced bone formation
(Klokkevold et al, 1996). In a study using methylpyrrolidinone chitosan in an animal
model of a bone defect, Muzzarelli et al (1993) found that the cationic nature and
chelating ability of this chitosan favored mineralization of neoformed bone tissue, while
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control defects showed only minimal bone formation originating only from pre-existing
bone or from the periosteum (Muzzarelli et al, 1993).
Studies exploring the use of chitosan to potentiate neochondrogenesis have shown
similar trends, such as the ability of chitosan to promote the maintenance of the
chondrocyte

phenotype

and

biosynthesis

of

extracellular

matrix

components,

glycosaminoglycans and type II collagen, when grown on two-dimensional substrates of
chitosan (Lahiji et al, 2000) or chitosan hydrogels (Sechriest et al, 1999).

Potential Advantages of Chitosan to Synthetic Polymers
Chitosan may have certain advantages over the more widely studied synthetic
polymers used in cartilage tissue engineering applications. One advantage may be the
relatively easy preparation of chitosan substrates. Chitosan powder is soluble in mildly
acidic solutions, below pH 6.5, except in solutions containing sulfuric acid or phosphoric
acid, and is most commonly dissolved in formic acid or acetic acid. Once dissolved,
chitosan solutions can be either centrifuged or filtered to remove any undissolved
particles, after which it can be easily formed into bulk porous scaffolds through a simple
freezing and lyophilization process.

Ice crystals that nucleate during freezing are

removed from the frozen solutions by lyophilization, which creates an interconnecting,
porous matrix. Furthermore, there is evidence that microstructural properties of porous
scaffolds can be controlled by varying the chitosan concentration, molecular weight,
percent deacetylation, degree of crystallinity, and the rate of freezing of the solution. For
example, the pores become larger as the rate of freezing decrease (Madihally and
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Matthew, 1999). Chitosan crystallinity can be controlled by reacting dissolved chitosan
with aqueous, dilute nitrous acid, which depolymerizes chitosan chains by reacting with
amino groups and cleaving the polymer at the b-glycosidic lingages. The rate of this
depolymerization reaction was found to be independent of molecular weight (Allen and
Payron, 1995). Controlling the crystallinity of chitosan may provide another means by
which to control the microstructural properties of porous chitosan scaffolds and the rate
at which they degrade. Furthermore, chitosan’s free hydroxyl and amino groups provide
an easy means of derivitization of this polymer and easy attachment of other bioactive
side groups.
Processing procedures involved in creating synthetic polymer matrices for tissue
engineering often include time, labor, and money intensive methods whose results are not
always reproducible. Synthetic polymer processing can also involve the extensive use of
toxic solvents. In the case of solvent casting used to prepare thin membranes, results are
often less than desirable with respect to pore interconnectivity and can only be used to
produce very thin membranes. Other processes including emulsion freeze-drying and
thermally induced phase separation technology are very dependent upon the user and the
technique employed. Emulsion freeze-drying is a process by which an emulsion, which
consists of small monomer particles (0.05 - 0.5 mm) surrounded by a surfactant in water
to which an initiator is introduced to start the polymerization process. The end product is
a stable latex in water, which is freeze dried to recover the polymer (Tadmor and Gogos,
1979). Thermally induced phase separation technology involves using a latent solvent ,
one that is a high-boiling, low molecular weight solvent for the polymer at hight

19
temperatures, but a nonsolvent at lower temperatures, to cool a polymer mixture to a
point of thermal separation. At this point the solvent phase can be extracted to recover
the polymer phase (Fried, 1995).
Though some groups have been very successful in precisely controlling the
properties of their polymers by using rapid prototyping and fused depositing modeling
techniques, these are also extremely time consuming and expensive (Hutmacher, 2000).
Therefore, the simplicity involved in producing chitosan matrices helps make it an
attractive alternative to synthetic polymers used in tissue engineering.
Chitosan matrices also display strong cell adhesion properties without further
processing, due to its cationic nature and high charge density. Often times, synthetic
polymers require the blending of two or more polymer types, such as poly-L-lactide
(PLLA) and poly (D,L-lactide co-glycolide) (PLGA) to induce optimal cell adhesion
(Cohen et al, 1993). Furthermore, given that the chemical structure of chitosan is similar
to that of glycosaminoglycans and hyaluronic acid, which have been implicated as
important stimulators of chondrogenesis, chitosan may also share this and other
characteristics with these molecules.

Chitosan is also able to form insoluble ionic

complexes with these molecules, which may aid in the integration of chitosan implants
with native tissues (Suh and Matthew, 2000). In light of these promising characteristics
of chitosan, the present research is aimed at an initial investigation of using threedimensional, porous chitosan scaffolds as cell substrates for cartilage tissue engineering.
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Statement of Hypotheses
The primary hypothesis was that the simple freezing and lyophilization of a
chitosan-acid

solution

would

interconnecting porous structure.

produce

bulk chitosan matrices possessing an

To test this hypothesis chitosan scaffolds were

fabricated through the simple freezing and lyophilization of a chitosan-acid solution.
Chitosan-acid solutions were analyzed for viscosity, and completed scaffolds were
analyzed by mercury intrusion porosimetry (MIP), scanning electron microscopy (SEM),
mechanical compression, and in degradation tests to determine optimal conditions for
producing these matrices. The secondary hypothesis was that porous chitosan scaffolds
would support neochondrogenesis (i.e. the synthesis of a cartilaginous matrix by
chondrocytes) in vitro. This entailed evaluations of chondrocyte attachment, viability,
morphology, and biosynthesis of cartilaginous extracellular matrix (ECM) components.

CHAPTER II
METHODS AND MATERIALS
Experimental Design
To address the first hypothesis, chitosan scaffolds fabricated for cartilage tissue
engineering must be highly porous and degrade at a rate consistent with the rate of new
tissue formation. The goal was to produce degradable scaffolds with a target overall
porosity between 90%-95%, consisting of pores with an average diameter between 100300 mm. In an effort to find the best process for creating such scaffolds, parameters
including the acid used as the solvent for the chitosan powder, the size and shape of the
container used to freeze the solutions, and the rate of freezing of the solutions were
varied. The viscosities and pH’s of these solutions were also determined and compared.
Solutions were frozen in either 35mm petri dishes or plastic vials and lyophilized to form
bulk, porous scaffolds. Once lyophilized, chitosan scaffolds were analyzed for surface
morphology by scanning electron microscopy (SEM).

Scaffolds were scanned and

evaluated for surface pore size and the appearance of an interconnecting pore structure.
Scaffolds were also analyzed in two-dimensional sections after being embedded,
sectioned, stained and photographed under a bright field microscope. The images were
then digitized and evaluated for pore fraction, average pore diameter, and overall twodimensional porosity.
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Representative scaffolds were sent to Micrometertics, Norcross, GA, for threedimensional evaluation by mercury intrusion porosimetry.
An additional ten scaffolds having a thickness of 6.35 mm and diameter of 12.7
mm, underwent mechanical evaluation. These scaffolds were assessed using a stress
relaxation test to determine an equilibrium compression modulus.
Finally, scaffold degradation was analyzed. Methods were adapted from ASTM
F-1635-95, Standard Test Method for Testing the In Vitro Degradation of Poly (L-lactic
Acid) Resin and Fabricated Form for Surgical Implants.

Eight test scaffolds were

incubated in complete culture medium containing 500 mg/ml chick egg white lysozyme,
while eight control scaffolds were incubated with complete culture medium only. Test
and control scaffolds were divided into four groups corresponding to four time periods of
incubation in test and control solutions. The dry weights of the scaffolds were measured
before the beginning of the incubation period, and the dry weights of two test and two
control scaffolds were measured at one, four, seven, and fourteen days following the start
of the test. Scaffolds were 5 mm in diameter ´ 2mm thick (0.0125 cm2). Two milliliters
of solution was used for each scaffold, which yielded a ratio of solution volume to
scaffold surface area of 160:1. A ratio of at least 100:1 is suggested by the standard.
To address the second hypothesis ten chitosan scaffolds (5 mm in diameter ´
2mm thick) were seeded with porcine chondrocytes from three-week old pigs (5 ´ 105
cells/ml) and cultured in a 50 ml rotary bioreactor vessel for up to 28 days. After 48
hours, two scaffolds were harvested, and analyzed for cell attachment using SEM or
viability using the LIVE/DEAD cell viability/cytotoxicity assay (LIVE/DEAD Cell
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Viability/Cytotoxity kit, Molecular Probes, Eugene, OR). After one, two, three, and four
weeks, two of the remaining scaffolds were harvested, fixed, embedded, and analyzed for
the presence of proteoglycan and type II collagen-rich ECM by histological and
immunohistochemical methods.
In a later test, three 5 mm diameter ´ 2mm thick scaffolds were seeded with threeweek porcine chondrocytes (16 ´ 106 cells/ml) and cultured in a 10 ml rotary bioreactor
vessel. All three scaffolds remained in culture for the 28-day period and were then
analyzed as described earlier.

Experimental Methods
Scaffold Fabrication and Analysis
To begin, 86% deacetylated, powdered chitosan with a molecular weight of
200,000 g/mol (Vanson, Inc., Redmond, WA) was dissolved in 0.2 M acetic acid and 1%
solutions of acetic, formic, and propionic by stirring for 48 hours. Once dissolved, the
pH of each solution was tested with a pH meter, and their viscosities were tested using a
Brookfield viscometer. The #2 spindle was used to test the solutions at motor speeds
ranging from 5 to 30 rpm. Viscosities were then plotted as a function of shear rate to
evaluate the validity of comparing the viscosities of the different solutions to one another
within this range of shear rates.
Chitosan-acid solutions were poured into 35mm polystyrene petri dishes to a
depth of approximately 5 mm and frozen at -27°C or into 12.7 mm diameter plastic vials
to a final volume of 7 ml and frozen at -9°C. The solutions were allowed to freeze for 48
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hours. Solutions in 35 mm petri dishes were then moved to a -80°C freezer where they
were kept until lyophilization. The frozen chitosan cores from the plastic vials were
removed from the vials by inversion after brief submersion in a 37°C water bath before
being moved to the -80°C freezer. Frozen solutions were then lyophilized at -40°C for 24
hours or until completely dry. Lyophilization of scaffolds causes the removal of ice
crystals from the frozen solutions, which produces the interconnecting, porous structure
of the scaffolds.
To evaluate the time needed to freeze chitosan solutions, a thermocouple was
inserted into one of the solutions frozen in a 35 mm petri dish during the freezing
process. Temperatures were recorded every 10 minutes and a graph was constructed of
temperature versus time using the collected data.

Microstructural Characterization
Lyophilized scaffolds were evaluated for surface morphology by examination
under SEM, for three-dimensional microstructural properties using mercury intrusion
porosimetry (MIP), and for two-dimensional properties using embedding, staining, and
imaging techniques.
To analyze the surface characteristics of lyophilized scaffolds using SEM, they
were first mounted on specimen holders with carbon tape and then sputter-coated with
gold palladium to make them conductive. One three-minute coating was sufficient to
eliminate charging inside the scope. Specimens were then simply placed in the SEM
scope and visualized using secondary electron detection mode.
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One scaffold from each fabrication technique was sent for three-dimensional
evaluation by MIP on an Autopore IV 9500 (Micromeritics, Norcross, GA). MIP is
based on the premise that a non-wetting liquid, such as mercury, will only intrude pores
under pressure.

Pore diameter is calculated according to the Washburn equation

(Washburn, 1921):
p = (-4gcosq)/d
Where p is the pressure required to force mercury into a pore of entry diameter d, g is the
mercury surface tension, and q is the contact angle between mercury and the sample. The
contact angle of mercury on chitosan is 130 degrees, and mercury surface tension is 485
dynes/cm. A total of 266 low- and high-pressure data points in the range of 1.2 kPa to
413.7 MPa are collected to provide a high-resolution profile of mercury uptake.
Scaffolds from each fabrication technique were embedded in glycolmethacrylate
(Immunobed, Polysciences, Niles, IL), sectioned to 7 mm using a rotary microtome, and
mounted on slides to be stained and evaluated in two-dimensions.

Chitosan’s

polycationic nature allows it to absorb anionic dyes, such as eosin, which was used to
highlight the chitosan on the sections. Sections were mounted with glass coverslips using
Permount (Fisher Scientific, Fair Lawn, NJ) and photographed with bright-field
microscopy. Once digitized, the images of sections were analyzed using NIH Image for
overall porosity and pore diameter.
dimensional analyses were compared.

The results from two-dimensional and three-
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Mechanical Testing
Ten scaffolds from each fabrication technique having a thickness of 6.35 mm
were mechanically tested in compression. These scaffolds were fully rehydrated before
being tested. They were compressed in 5% increments to 50% of their initial height
using the fixture shown in figure 3. It consists of a micrometer head connected in series
with a ± 50 N load cell. The micrometer head was used to precisely control each step of
compression. Scaffolds were held at each step for five minutes and then compressed to
the next strain level. Stress relaxation was monitored and recorded using LabVIEW
software. The data were then used to compute an equilibrium compressive modulus for
each type of chitosan scaffold tested.
Micrometer Head
± 50 N Load Cell

Chitosan Sample

Figure 3. Mechanical Testing Fixture Used to Compress Chitosan Scaffolds
Degradation
To assess degradation of chitosan scaffolds in vitro, eight fully rehydrated
scaffolds were incubated in 2 ml of complete culture medium containing 500 ug/ml chick
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egg white lysozyme. This concentration of lysozyme was chosen in order to produce an
effect, and is not necessarily the concentration present in vivo. Eight control scaffolds
were incubated in complete culture medium without lysozyme. Incubations were done in
a 37°C humidified 5% carbon dioxide (CO2) incubator throughout the two-week study.
The dry weight of each scaffold was determined before incubation. The dry weights of
two control and two test scaffolds were measured again after one, four, seven and
fourteen days of incubation. Scaffolds were dehydrated in a graded ethanol series before
being measured. Scaffold weights were then recorded and compared to their initial dry
weight. Degradation was determined as the percentage of weight loss as described by
Section 8 of ASTM F-1635, and according to the formula:
% WL =[(W0 – W)/W0]*100,
where WL was weight loss, W0 was initial weight, and W was weight after degradation.
Statistical significance for main effects was determined using a two way ANOVA at the
95% confidence level, and treatment effects were determined using Tukey’s honestly
significantly different test also at the 95% confidence level.

Solutions Viscosities
The viscosities of chitosan-acid solutions were tested using a Brookfield
Viscometer. The #2 spindle was used to test the solutions at motor speeds ranging from 5
to 30 rpm. Viscosities were then plotted as a function of shear rate to evaluate the
validity of comparing the viscosities of the different solutions to one another within this
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range of shear rates. Statistical significance was determined for the viscosities using a
one way ANOVA at the 95% confidence level.

Cell Isolation and Culture
Initially, ten scaffolds were prepared for cell culture.

They were partially

rehydrated in a graded ethanol series (100%, 95%, 80%, 70%) to a 70% ethanol solution
at which time they were cored using a 5 mm diameter core punch. These cores were then
added to a fresh 70% ethanol solution and remained there overnight. This 24-hour
incubation facilitated scaffold being bacteriostatic.

After this 24 hour incubation,

rehydration was completed with a solution of 50% ethanol to a final solution of
phosphate buffered saline (PBS) containing 2´ antibiotics-antimycotics. The scaffolds
were incubated for at least 24 in this PBS solution to help ensure sterility. Before being
seeded with cells, scaffolds were incubated with sterile fetal bovine serum (FBS) for
twenty-four hours to coat the scaffolds with cell-essential proteins and facilitate cell
attachment.
Chondrocytes were isolated from native cartilage harvested from the femoral
chondyles of three-week-old pigs, using aseptic technique. Cartilage was minced with a
scalpel, and the pieces were incubated with 1% type 2 collagenase dissolved in a 5% fetal
calf serum solution in Dulbecco’s Modified Eagles Medium (DMEM) and stirred
overnight.

This enzymatic solution digested the cartilaginous matrix components,

releasing the cells into the medium. The solution was filtered through a 100 mm sterile
filter and subsequently centrifuged at 1000 rpm for eight minutes to produce a cell pellet.
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After the medium was removed from the pellet, the cells were resuspended at 5 ´ 105
cells/ml in complete cell culture medium (DMEM, 1% L-glutamine, 1% antibioticantimycotic, 10% FBS, and 50 ng/ml ascorbate) in a 50 ml rotating-wall bioreactor vessel
(Synthecon, Houston, TX). The chitosan scaffolds were added to the vessel, where they
remained in culture with the chondrocytes for up to 28 days. Cultures were kept in a
37°C humidified CO2 incubator.
The rotating-wall bioreactor vessel system has been shown to be the optimal
method of culturing three-dimensional cartilage constructs.

Freed and Vunjak-

Novakovic, 1995, showed that when rotating such that constructs are in a state of
constant freefall, that bioreactor culture conditions most closely mimic in vivo
chondrogenesis conditions (Freed and Vunjak-Novakovic, 1995). They also showed that
this method of culture helps modulate the composition and mechanical properties of
tissue engineered cartilage.

Vunjak-Novakovic et al, 1998, found that cartilage

constructs cultured in microgravity (in free-fall in a bioreactor) resulted in the highest
fractions of regenerated tissue and glycosaminoglycans (GAG), when compared to
constructs grown in other culture conditions including orbital mixing cultures, solid-body
rotation, and spinner-flask culture. This environment also helps promote the maintenance
of the chondrocyte phenotype throughout extended culture times (Freed and VunjakNovakovic, 1997).
The speed of our bioreactor was adjusted to 17.5 rpm, which allowed constructs
to stay in a state of constant free-fall throughout the duration of the study. As scaffolds
rotated in this low shear environment, nutrients were able to reach cells that have
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attached to the interior of the scaffolds, and at the same time, metabolic waste products
were moved away from the cells and out into the medium.

In other words, this

environment allows efficient mass transfer. The medium was changed every three days,
at which time, the cultures were supplemented with L-ascorbic acid to a final
concentration of 50 ng/ml.

L-ascorbic acid is necessary for cartilaginous matrix

synthesis.
Another trial was performed with three scaffolds fabricated using 1% formic acid
as the solvent. These scaffolds were chosen based on results from the degradation study.
Because higher initial cell density has been shown to increase the quantity and quality of
engineered cartilage (Puelacher et al, 1994), this trial was performed with an initial cell
density of 16 million cells/ml of culture medium. Scaffolds were seeded in a 10 ml
culture vessel and after 24 hours were moved to a 50 ml culture vessel at which point 20
million more cells were added. In this trial, all scaffolds remained in culture for four
weeks.

Cell Attachment and Viability
Cell attachment was evaluated after 48 hours for the first trial, by performing a
hemocytometer count of cells remaining in the medium. The number counted was
subtracted from the initial cell density to determine the number attached to each scaffold.
One scaffold from the first trial was also fixed in 2.5% glutaraldehyde, dehydrated in a
graded ethanol series, and chemically dried with Hexamethyldisilazane (HMDS) for
viewing by SEM. This construct was mounted with carbon tape on a specimen holder

and sputter-coated with gold-palladium to render it conductive.
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Two, three minute

coatings was necessary to prevent charging in the scope. The specimen was viewed in
secondary electron detection mode on a LEO Stereoscan 360 (MSU Electron Microcopy
Center) and its surface evaluated visually for cell attachment.
Cell viability was also evaluated after the 48 hour seeding period for the first trial
and was confirmed by intracellular esterase activity as indicated by the green
fluorescence of calcein that is enzymatically converted from calcein AM in live cells.
Dead cells were simultaneously recognized by their red fluorescence, due to the binding
of nucleic acids to ethidium homodimer-1 that enters the cells through damaged
membranes. Samples were viewed qualitatively on a LEICA TSNSC Confocal Laser
Scanning Microsope (MSU Electron Microsopy Center). The 48 hour cell attachment
and viability analyses were not performed on scaffolds from the second trial because the
scaffolds were moved to the larger volume vessel after 24 hours. Also there were only
three scaffolds, which were all needed at the 4-week end point for other analyses.

Histology and Immunohistochemistry
The remaining scaffolds in the first trial were maintained in culture for 10, 18, and
28 days. All scaffolds from the second trial were harvested after 28 days. Scaffolds from
first trial were processed for either histology or immunohistochemistry, while scaffolds
from the second trial were processed only for histology. All samples were fixed in
Carnoy’s solution, which is a 3:1 solution of 95% ethanol to glacial acetic acid. This
fixative was recommended by the Developmental Hybridoma Bank, Iowa City, Iowa, for
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use with the II-II6B3 anti-type II collagen antibody, which was used for
immunohistochemical procedures. After at least two hours in the fixative, samples were
washed extensively with 95% ethanol to eliminate residual acid, and were then washed
several times in 100% ethanol to complete dehydration. Samples were cut in half and
were embedded in glycolmethacrylate (Immunobed, Polysciences, Niles, IL) in a vacuum
chamber.
For routine histology, glycolmethacrylate blocks containing samples were
mounted in the specimen holder of a rotary microtome and sectioned to 7 mm. Sections
were placed on charged glass slides and allowed to dry for 24 hours. Sections were
stained with hematoxylin and eosin and counter stained with toluidine blue to highlight
proteoglycan-rich ECM (Kiernan, 2000). Slides were subsequently dehydrated, cleared
in xylenes, and mounted with glass coverslips using Permount. Using this staining
technique, cell nuclei stain blue, and areas of ECM that contain proteoglycans stain
metachromatically.
Samples that were to be analyzed immunohistochemically for type II collagen,
using a HistoStain SP Kit (Zymed, San Francisco, CA) were cut to 8 mm. After being
placed on charged slides and allowed to dry, sections were rehydrated in a graded ethanol
series to PBS and incubated with 2500IU/ml hyaluronidase (H6254, Sigma, St. Louis,
MO) for 5 minutes. This enzyme digests any hyaluronic acid in the extracellular matrix
that may be blocking antigenic-binding sites.

After washing in PBS, section were

incubated for 10 min with a peroxidase solution (1 part 30% hydrogen peroxide to 9 parts
100% methanol) and washed in PBS (5 ´ 5 min). Sections were then incubated with 10%
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non-immune goat serum to block non-specific antigen binding sites. At this point, the
blocking solution remained on negative control sections, while experimental sections
were incubated for 120 min with a monoclonal antibody to type II collagen in a 37°C
humidified CO2 incubator. After another 5 ´ 5 min washing in PBS, all sections were
incubated for 30 min with a biotinylated secondary antibody at 37°C and subsequently
washed.

Sections were then incubated for 30 min with a streptavidin-peroxidase

conjugate, 10 min with a substrate-chromagen (hydrogen peroxide-DAB) mixture, and
rinsed for 2 min with distilled water. Finally, sections were stained for 3 min with
hematoxylin, and underwent a final rinsing for 30 sec in PBS and 2 min in distilled water.
The sections were then dehydrated in a graded ethanol series, cleared in Xylene, and
mounted with glass coverslips using Histomount (Zymed Laboratories, San Francisco,
CA). Areas where type II collagen was present on experimental sections stain orangebrown, and the cell nuclei stain blue.
microscopy.

Sections were viewed under bright-field

CHPATER III
RESULTS
Experimental Results
Scaffold Fabrication and Analysis
Bulk, porous chitosan scaffolds were easily fabricated using a simple freezing and
lyophilization process. Scaffolds fabricated by dissolving 86% deacetylated chitosan
powder in 0.2 M acetic acid and freezing in 35 mm petri dishes at –20°C, revealed a what
appeared to be an interconnecting porous structure when viewed under SEM (Figure 4A);
however, when visually insepected, scaffold surfaces that had been in contact with
polystyrene, displayed a very different surface structure that was less porous than
scaffolds surfaces that did not contact petri dish surfaces (Figure 4B). Upon visual
inspection of SEM microphotographs of scaffolds fabricated by dissolving 86%
deacetylated chitosan powder in 0.2 M acetic acid and subsequently freezing in 12.7 mm
diameter vials at –9°C, appeared to possess a more porous structure than scaffolds frozen
in 35 mm petri dishes. A representative microphotograph is shown in figure 5.
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Figure 4 A. 100X SEM of Porous Chitosan Scaffold Surface B. 100X SEM of Porous
Chitosan Scaffold Surface that was in Contact with Polystyrene Surface

200 mm

Figure 5. 100X SEM of Porous Chitosan Scaffold Frozen in Plastic Vial at –9 C
Figure 6 represents that temperature verses time data for the freezing of chitosan
solutions in 35 mm petri dishes in a -27°C freezer. The temperature of the solutions
dropped in a parabolic fashion until the solution reached 0°C, at which point the
temperature remained constant until the entire volume of solution was frozen. The
temperature then began to decrease further to reach the temperature of the freezer. The
time taken from the solutions to reach equilibrium at 0°C was approximately 2 hours and
20 minutes for this solution.
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Figure 6. Temperature Vs. Time for Freezing of Chitosan Solutions in 35 mm Petri
Dishes at -27°C
Microstructural Characterization
Three-dimensional microstructural properties, as determined by MIP analysis, for
one scaffold made by freezing in a 35 mm petri dish and one scaffold made by freezing in
a 12.7 mm vial is shown in Table 1. Both scaffolds were made using acetic acid as the
solvent.
Table 1. Scaffold Properties Determined Using MIP
Freezing Container Bulk Density Total Pore Area Total Porosity
35 mm petri dish

0.06 g/ml

0.8 m2/g

80.70%

12.7 mm vial

0.17 g/ml

0.702 m2/g

94.2%
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The overall porosity of the scaffold frozen in the 12.7 mm plastic vial was 94%,
while the overall porosity of the scaffold frozen in the 35 mm plastic petri dish was only
80%. By visual inspection, scaffolds frozen in vials appeared to have much larger pores
in interior regions (the region used for cell culture), while those pores closer to the
exterior where much smaller. Note, only one scaffold of each type was sent for analysis
because of cost constraints; hence, the lack of statistical analysis.

Mechanical Testing
The compressive modulus of porous chitosan scaffolds frozen in 35mm
polystyrene petri dishes was found to be 3.5 ± 0.4 kPa in the 50% compression range.
While this is similar to the compressive modulus of other common culture mediums such
as alginate or agarose, it is much softer than healthy hyaline cartilage, which has a
compressive modulus of 1 MPa in healthy individuals (Mow et al, 1991). Figure 7 shows
the stress vs. strain curves for three porous chitosan scaffolds that were representative of
those used in this study.
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Figure 7. Engineering Stress Vs. Strain Curve for Chitosan Scaffolds
Solution Viscosities
The viscosities of chitosan-acid solutions were determined to be Newtonian, as
determined by their plots of viscosity versus shear stress being linear (Figure 8). In this
plot, viscosity does not change significantly as shear stress increases for any solution.
Figure 9 compares shear rate versus shear stress for three different solutions. Because
solutions viscosities were not determined to be significantly different from one another
(p-value > 0.05), this property was determined not to be an indicator of degradation rate
of the scaffolds created using these solutions.
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Figure 8. Viscosity Vs. Shear Rate for Chitosan-Acid Solutions
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Degradation
Upon visual inspection of scaffolds exposed to lysozyme for four days, it was
evident that formic acid scaffolds degraded most quickly, followed by propionic acid
scaffolds. Acetic acid scaffolds did not appear to have degraded at all and looked similar
to control scaffolds at this time point (Figure 10).

Figure 10. Acetic Acid (A), Propionic Acid (P), and Acetic Acid Control Scaffolds (C)
After 4 Days
Scaffolds incubated with lysozyme degraded significantly faster than control
scaffolds (p-value > 0.05).

Formic acid scaffolds were determined to degrade

significantly faster than both propionic acid scaffolds and acetic acid scaffolds, while
there was no significant difference between the rate of degradation of propionic acid
scaffolds and acetic acid scaffolds. Figure 11 shows the means plot for the mean weight
loss with respect to acid type of the scaffolds.
differences in weight loss.

The asterisks represent significant
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Figure 11. Means Plot for Weight Loss Vs. Acid Type (P = Propionic Acid Scaffolds,
A = Acetic Acid Scaffolds, F = Formic Acid Scaffolds)
Cell Attachment and Viability
From the hemocytometer count of unattached cells from the first cell culture trial,
it was determined that 2.5 ´ 105 cells attached to each of 10 scaffolds after 48 hours.
SEM microphotographs showed a fairly uniform covering of cells on the scaffold surface
(Figure 12A) and the maintenance of the spherical morphology characteristic of a
chondrocyte by attached cells (Figure 12B). The cell viability assay also showed a fairly
uniform covering of cells on the scaffold and a large number of viable cells. Though
some dead cells were visible, though some dead cells were visible, it was difficult to
estimate their numbers due to the chitosan displaying the same red color as the dead cells.
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Figure 12 A. 100X SEM Micrograph of Cells Attached to Chitosan Scaffolds After 48
Hours B. 1500X SEM Micrograph Showing the Spherical Morphology of
Cells Attached to Chitosan Scaffolds After 48 Hours
Histology and Immunohistochemistry
Histological sections from day 18 scaffolds from trial one showed that cells were
attached to the chitosan and had begun to fill pores. Some cell-dense areas stained
metachromatically with toluidine blue, indicating the presence of proteoglycan-rich ECM
(Figure 13A and B).

These biosynthetic phenomena were mostly confined to the

periphery of the scaffolds because those cells on the exterior of the scaffolds tended to
form a “shell” and effectively starved any cells that had attached or migrated to the
interior of the scaffolds. It was also evident from histological sections than some closed
pore volume existed within the scaffold microstructure preventing cells from attaching to
all interior surfaces. Scaffolds from 28 days showed similar trends (Figure 14A).
Histological sections from 28 day scaffolds from the second trial revealed a larger
number of cells in interior pores of the scaffolds. These cells as well as those closer to
the exterior of the scaffolds did produce proteoglycan-rich ECM, which is highlighted by
the metachromatic staining shown in figure 14B.

These histological sections both
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imaged at 40X were also used to compare the microstructures of the scaffolds at the 28
day time point. The microstructure of the scaffold shown in figure 14A and used in the
first trial was clearly denser than that of the scaffold shown in figure 14B, used in the
second trial.
The cell clusters that displayed methachromasia with toluidine blue from the first
trial were the same areas that stained positively (orange-brown) for type II collagen
(Figure 15 A and B). Most collagen synthesis appeared to be pericellular, or confined to
those regions immediately adjacent to cells. Constructs analyzed after 28 days showed
similar trends.

A

B

Figure 13A. And B. Histology Sections from Day 18 Scaffolds Stained for Proteoglycans

A

B

Figure 14 40X Histology Sections from Day 28 Acetic Acid (A) and Formic Acid (B)
Scaffolds
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A

B

Figure 15A. and B. Immunohistochemical Histology Sections from Day 18 Scaffolds
Stained for Type II Collagen

CHAPTER IV
SUMMARY AND DISCUSSION
Summary
Chitosan scaffolds possessing an interconnecting porous structure were easily
fabricated using a simple freezing and lyophilization process. The scaffolds that resulted
from freezing chitosan solutions in 35mm petri dishes at –20°C appeared to limit scaffold
performance because of their low porosity. This problem was addressed by altering
scaffold fabrication parameters including the shape and size of the container used to
freeze the solutions and the temperature at which the solutions were frozen. By freezing
the chitosan in cylindrical vials at –9°C, porosity was increased to 94%; however, results
from MIP suggest that the average pore diameter was smaller in these scaffolds. It is
believed that this was due to the average pore diameter being an average of all pores and
not just those contained within the area used for culture, which were cut from the center
most portion of the larger cylindrical chitosan plugs. Visually, pores in this area were
obviously larger than those in the areas not used in culture and larger than those in
scaffolds frozen in 35 mm petri dishes at –20°C.
Scaffolds showed minimal mechanical integrity before cells were added to them,
but were strong enough to support cell attachment and growth and remained in tact
through the culture period in the rotating bioreactor.
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Scaffold performance was also measured by their ability to biodegrade during the
28-day culture period. Degradation tests conducted in the absence of cells suggested that
scaffolds fabricated using formic acid as the solvent would degrade an average of 67%
faster than their acetic acid counterparts. This may lead one to believe that acetic acid
may somehow inhibit the action of the lysozyme, the enzyme responsible for breaking
down chitosan, while formic acid may not. It is possible that perhaps acid salts remained
in the scaffold microstructure after volatile acid was removed during lyophilization. This
suggests than a relationship may exist between these salts and the lysozyme’s ability to
attack key complexes in the chitosan structure. This proposed relationship between the
acid salts and lysozyme should be investigated further before any strong conclusions are
drawn concerning lysozyme inhibition. It should also be noted that when used in culture
both scaffold types remained largely unchanged.
In terms of their ability to truly organize the cells in three dimensions, the more
porous scaffolds were more successful. When cultured on the less porous scaffolds, large
numbers of cells were unable to penetrate to the interior of the scaffolds, and those that
did, appeared to be effectively starved by cells forming a shell around the exterior of the
scaffolds.

When more porous scaffolds were used in culture, cells were able to

penetrated further into the scaffold microstructure; however, this may have been due in
part to the higher cell seeding density. Both scaffold types were judged equally as
capable of supporting the biosynthesis of a proteoglycan and type II collagen-rich
extracellular matrix.
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Future Directions
It appeared that by changing the morphology of the freezing container and the rate
at which solutions were frozen, that porosity was fairly easily altered. It would be useful
to know exactly how changing each parameter affected the porosity.

Using the

thermocouple to monitor the freezing rates of solutions over a range of temperatures
would be one way of answering at least the question of how temperature affects the
porosity. However, perhaps a more versatile method would be to create a finite element
model of the system in which one would have more freedom in varying parameters and
would be able to visualize the effects more quickly.
Perhaps other parameters such as crystallinity of the chitosan solutions and the
physical state of the solutions before freezing are also responsible for not only affecting
final porosity, but also affecting degradation rate and overall scaffold performance. With
this in mind, current research is being conducted using Nuclear Magnetic Resonance to
determine exactly what is present in chitosan solutions made with different acids. This
information may be useful in determining what inhibits or enhances degradation of
scaffolds. Solutions are also being cast as films for viewing under a polarizing light
microscope to determine the crystallinity of solutions, as crystallinity may play a role in
porosity and degradation rate. There has also been some evidence that by allowing a
chitosan solution to gel before freezing may have an effect on porosity. Tests to evaluate
this theory are currently being conducted.
Still another avenue being investigated is the attachment of side groups to the
chitosan structure using available amino groups as reactive sites.

Possibilities for
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attachment include proteins that may enhance chondrogenesis, or other inert groups that
may serve to help control or predict the rate of degradation of the polymer during culture.
By further understanding the chemistry responsible for the scaffold’s physical properties
and performance, both chemically and in-culture, it may be possible to create specially
tailored chitosan scaffolds for specific applications.
Chitosan is a biopolymer with many promising characteristics including its
antimicrobial activity, its ability to bind cells and sustain their life, and the availability of
reactive groups for modifying its structure.

Chitosan may prove to be a useful

biomaterial for applications other than tissue engineering, as is currently being
investigated by others, including applications in artificial skin, nerves, would healing,
biological coatings, and drug delivery. The present research showed chitosans usefulness
for cartilage tissue engineering, and also began to show its versatility by discovering the
ease with which this material can be manipulated to fit certain circumstances. Given that
chitosan is an abundant waste product of the shellfish industry, is relatively inexpensive
to researchers, and is fairly easily processed, this polymer should be further investigated
for wide use as a biopolymer in medical applications and may provide a useful and less
expensive alternative to conventional materials currently being used.
Conclusions
This discovery-based research has opened several avenues of thought concerning
chitosan as a biopolymer for tissue engineering applications. In this work, two different
chitosan scaffold types were generated that were able to support the attachment and
viability of chondrocytes, and help to maintain their spherical morphology characteristic
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of the chondrocyte phenotype. Cells attached to both types of scaffolds also showed a
biosynthetic profile including proteoglycans and type-II collagen. However, scaffolds
frozen at a slower rate, and therefore possessing greater total porosity, supported this
activity through a greater volume than scaffolds frozen more quickly and possessing a
denser microstructure.

Through both trials, scaffold microstructure and degradation

characteristics seemed to be the limiting factors. Though scaffolds frozen at a slower rate
were more porous, it is possible that both scaffold types possess a certain amount of
closed pore volume that prevents complete penetration of cells into all void areas;
however, results were promising and did indicate that given optimal chitosan scaffolds,
that this polymer might prove to be a useful alternative to synthetic polymers in cartilage
tissue engineering applications.
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